Skip to search formSkip to main contentSkip to account menu

Recombinant Platelet Factor 4

Known as: rhPF4, CXCL4, Platelet Factor 4 
A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding… 
National Institutes of Health

Related topics

Related topics

3 relations
NCIt Antineoplastic Agent Terminology

Broader (1)

Platelet Factor 4

Narrower (1)

Platelet Factor 4, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
CXCL 4 in atherosclerosis : Possible roles in monocyte arrest and macrophage foam cell formation
Thromb Haemost 2007; 98: 917–918 In this issue of Thrombosis and Haemostasis, Sachais et al. demonstrate a critical role for… 
2017
2017
atherosclerosis , does not affect restenosis CD 40-CD 40 L : a Janus-faced interaction
The common denominator of arterial diseases is inflammation. Co-stimulatory molecules are essential to propagate and modulate… 
2016
2016
Blocking heteromerization of platelet chemokines ccl5 and cxcl4 reduces inflammation and preserves heart function after myocardial infarction
2015
2015
Serum CXCL4 Increase in Patients with Undifferentiated Connective Tissue Disease at Risk for Systemic Sclerosis Is Associated with Anti-Scl70 Antibodies and ICAM-1, a Marker of Endothelial Activation
2015
2015
CXCL4 plasma levels in patients with or without CAD.
2014
2014
Proteome-wide Analysis and CXCL 4 in Systemic Sclerosis
n engl j med 370;16 nejm.org april 17, 2014 1561 The authors propose that interferon-free regimens may be associated with a… 
2012
2012
Plasmodium falciparum Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of
clicking here. colleagues, clients, or customers by , you can order high-quality copies for your If you wish to distribute this… 
2009
2009
Heparin-Induced Thrombocytopenia (HIT) Syndrome
Heparin has been available as a clinical treatment and prevention for thromboembolic disease for half a century. Known… 
1995
1995
rPF4 does not cause pulmonary hypertension in humans.
1995
1995
Recombinant platelet factor 4 (rPF4) neutralizes heparin in patients undergoing coronary artery bypass